Cart
sales@molnova.com
(2R3S)-3-Phenylisoserine hydrochloride
CAS No. 132201-32-2
(2R3S)-3-Phenylisoserine hydrochloride( —— )
Catalog No. M20322 CAS No. 132201-32-2
(2R,3S)-3-Phenylisoserine hydrochloride is a serine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(2R3S)-3-Phenylisoserine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description(2R,3S)-3-Phenylisoserine hydrochloride is a serine derivative.
-
Description(2R,3S)-3-Phenylisoserine hydrochloride is a serine derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132201-32-2
-
Formula Weight217.65
-
Molecular FormulaC9H12ClNO3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.N[C@H]([C@@H](O)C(O)=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
6-Acryloyloxyhexyl p...
6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.
-
Maltooctaose
Maltooctaose is a low molecular weight carbohydrate obtained by starch hydrolysis. It is composed of a group of linear α(1-4)-linked D-glucose polymers and trace amounts of (1-6)-linked glucose condensed with a degree of polymerization of 8.
-
Lomibuvir
Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.
